In partnership with
September 4, 2025
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.
Today’s edition is supported by Pacaso, the modern way to co-own a luxury second home.
Texas’s attempt to ban THC collapsed as Dan Patrick’s crusade hit the wall of Abbott’s veto and a hemp industry too economically entrenched to kill. Whitney Economics data shows Texas hemp generated $4.3B in 2025 retail revenue and supports over 50,000 jobs, creating a constituency that proved more powerful than prohibition politics. Meanwhile, Green Thumb workers staged a Labor Day strike in Pennsylvania, THC beverages surged past $1.1B in sales, delta-8 use doubled in prohibition states, and Switzerland unveiled its full legalization framework.
And 🎧 a new episode of The Hybrid podcast drops this week, where cannabis policy, culture, and business intersect.
🌵 Track attempted prohibition
💰 Follow labor strikes and employee sentiment
🍺 Watch THC beverages make alcohol sweat
Start smarter. Move faster. Stay ahead.
Keep This Stock Ticker on Your Watchlist
They’re a private company, but Pacaso just reserved the Nasdaq ticker “$PCSO.”
No surprise the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. What is unique is Pacaso is giving the same opportunity to everyday investors. And 10,000+ people have already joined them.
Created a former Zillow exec who sold his first venture for $120M, Pacaso brings co-ownership to the $1.3T vacation home industry.
They’ve generated $1B+ worth of luxury home transactions across 2,000+ owners. That’s good for more than $110M in gross profit since inception, including 41% YoY growth last year alone.
And you can join them today for just $2.90/share. But don’t wait too long. Invest in Pacaso before the opportunity ends September 18.
Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Dan Patrick's year-long crusade to ban THC products in Texas collapsed Wednesday night as the second special session ended without House action on Senate Bill 6, despite the lieutenant governor calling it one of his "top five" bills in 17 years. The failure caps a remarkable political saga that began when Gov. Abbott vetoed Patrick's original ban (SB 3) in June, calling for regulation instead of prohibition and creating an unprecedented public rift between Texas's two most powerful Republicans. Last-ditch compromise efforts included Rep. Briscoe Cain's proposal for 2.5mg serving caps that industry estimates would have "wiped out 80% of currently legal sales," but even these managed restrictions couldn't bridge the divide between Patrick's moral panic and Abbott's economic pragmatism. The hemp industry's $10.3 billion total economic impact, 53,300 jobs, and $268 million in annual tax revenue ultimately created insurmountable political headwinds for prohibition. When Patrick acknowledged Wednesday that "lawmakers couldn't come to an agreement," it was really the session calendar that rendered the final verdict on Texas's largely unregulated THC market.
💡 Why It Matters: The THC ban's failure represents a seismic shift in cannabis prohibition politics, demonstrating that once hemp markets reach critical economic mass, even conservative supermajorities struggle to roll them back. Whitney Economics data reveals Texas hemp retail revenue jumped from $3.3 billion in 2023 to $4.3 billion in 2025, with 8,500 businesses reporting 72% profitability rates—creating a constituency that proved more powerful than Patrick's 17-year legislative reputation. The Abbott-Patrick split exposes deeper fractures within Texas GOP power dynamics, with Abbott's $86 million war chest and federal court appointments giving him leverage to resist Patrick's agenda when economic interests align against it. For other states watching Texas as a bellwether, the message is clear: prohibition becomes politically impossible once hemp industries achieve economic entrenchment, with regulators facing a choice between grudging acceptance or regulatory frameworks that preserve tax revenue while addressing safety concerns. The failure also signals to MSOs and hemp companies that Texas remains a viable expansion target despite conservative leadership, particularly as Abbott's regulatory approach suggests eventual normalization rather than elimination.
🧠 THC Group Take: Patrick's defeat reveals the fundamental contradiction in Republican cannabis policy: you can't simultaneously champion free markets and small government while banning profitable industries that employ tens of thousands of constituents. His increasingly unhinged press conferences, featuring dramatic displays of THC products and calling reporters "crazy,” exposed someone who mistook legislative procedure for actual political power, forgetting that even lieutenant governors must build coalitions beyond their own chamber. Abbott's calculated veto represented masterful political triangulation, allowing him to appear responsive to veteran groups and business interests while forcing Patrick to spend political capital on a losing battle during two special sessions. The real strategic insight here is how hemp's legal gray area creates policy stickiness: once delta-8 and THCA products establish retail footprints, the infrastructure costs of enforcement make prohibition economically prohibitive for cash-strapped state governments. Expect other red states to follow Texas's trajectory—initial tolerance leading to massive industry growth, followed by failed prohibition attempts, eventually settling on alcohol-style regulation that maximizes tax revenue while maintaining conservative credibility through age restrictions and local control.
Fast-moving headlines, flagged for what matters.
Shield Compliance's Financial Services Survey reveals a brutal disconnect between industry needs and political reality: while 97% of cannabis business leaders consider rescheduling "important" to long-term viability (61% say "extremely important"), they rate 2025 passage probability at just 34 out of 100. The survey found over 80% satisfaction with current banking providers despite access challenges, but 60% want payment innovation and nearly 30% are considering switching institutions for credit access. Strategic insight: operators are hedging against federal inaction by optimizing existing banking relationships while preparing for expanded services. Shield Compliance CEO Tony Repanich identified the core opportunity: "demand for credit access and payments innovation underscores significant opportunities for financial institutions ready to lean in, particularly as the creditworthiness of operators improves with market consolidation." (Marijuana Moment)
Teamsters Local 776 workers at Green Thumb Industries' York, Pennsylvania RISE dispensary launched a Labor Day strike after filing bad-faith bargaining allegations with the NLRB on August 28. The timing amplifies messaging around wage inequality as Green Thumb reported $1.1 billion revenue and CEO Ben Kovler received over $10 million in compensation while workers demand living wages. This marks Green Thumb's second major labor action in two years following a successful 2023 Illinois strike that secured 50% wage increases after 13 days. The Pennsylvania action targets just one of Green Thumb's 18 state dispensaries, suggesting strategic pressure rather than operational disruption, but establishes concerning pattern for MSOs as organized labor gains sophistication in targeting high-profile operators during peak revenue cycles. (Cannabis Business Times)
Whitney Economics' new beverage market analysis reveals THC drinks reached $1.1 billion in legal sales across 28 states, but this represents only a fraction of the $9.9-14.9 billion total addressable market. The space features 500-750 brands nationally with most averaging $2 million annually while top performers exceed $10 million, indicating significant consolidation opportunities ahead. Most strategically significant: the regulatory patchwork creates competitive moats, with products legal in 28 states, restricted in nine, dispensary-only in seven, and banned in six states. Chief Economist Beau Whitney attributes rapid expansion to "shifting consumer behavior, economic softening and federal regulatory changes" that help "backfill declining revenues across multiple industries, including beer, wine and distilled spirits." The supply chain complexity requiring testing at multiple production stages suggests significant barriers to entry for traditional beverage companies. (Yahoo Finance/Whitney Economics)
A nationally representative study in the American Journal of Preventive Medicine reveals 19.3 million U.S. adults have tried delta-8 THC, with usage spiking to 10.9% in prohibition states versus 5.5% in recreational markets. The regulatory arbitrage is stark: where delta-8 sales are unregulated, lifetime use hits 10.5%, dropping to 3.9% where states regulate sales and 4.5% where prohibited. Study author Eric Leas summarizes what should surprise absolutely no one: "These findings underscore that people don't just stop using cannabis when their state bans it," with consumers shifting "toward what is easy to get, even when that product is less studied or poorly regulated." File this under "no shit": the 2018 Farm Bill created a legal pathway for hemp-derived psychoactives sold in gas stations with zero oversight while regulated cannabis remains federally prohibited. Turns out prohibition just makes people buy worse weed. (ScienceBlog.com/UC San Diego)
The Department of Transportation is proposing new rules to update cannabis terminology in federal drug testing guidelines, replacing generic "THC" references with specific "delta-9 THC" nomenclature to align with Health and Human Services standards adopted earlier this year. The change addresses scientific confusion where HHS previously used "THCA" to refer to a marijuana metabolite (delta-9-tetrahydrocannabinol-9-carboxylic acid) while the cannabis industry uses "THCA" for delta-9 tetrahydrocannabinolic acid, a non-psychoactive compound. Under the proposed rules, DOT would refer to the THC metabolite as "delta-9 THCC" rather than "THCA" to eliminate ambiguity. The update applies to workplace drug testing of federal employees and comes alongside DOT's separate proposal to add fentanyl testing for federally regulated transportation workers. The 45-day comment period reflects broader federal struggles to standardize cannabinoid definitions as delta-8 THC and other hemp derivatives proliferate outside traditional regulatory frameworks. (Marijuana Moment)
Switzerland just released the complete text of its Federal Act on Cannabis Products for three-month public consultation, revealing a harm reduction-focused model that prioritizes regulatory defensibility over commercial opportunity. The framework features a federal online monopoly, complete vertical integration bans, THC-content-based possession limits (5g total THC), and mandatory non-profit principles that effectively neuter traditional cannabis business models. Most strategically significant: sales restricted to Swiss citizens and residents only, creating a closed-loop system that sidesteps EU free movement obligations while establishing regulatory precedent for other Schengen Zone countries. The consultation runs through December 1, with implementation potentially starting next year pending parliamentary approval. (Business of Cannabis)
Industry marketers are pushing back against the "race to the bottom" pricing dynamics with arguments that brands like Cookies, Miss Grass, and Kiva prove emotional connection trumps THC percentages and price points. Jetty Extracts' internal data confirms cost and cannabinoid content drive sales, but "creating a brand that stands for more than price and potency is how companies can substantiate any price point above the commodity." The strategic insight buried in consumer research: budtenders remain the critical influence point, with Reddit discussions repeatedly citing their recommendations as purchase drivers. Marketing expert Angela Pih's bottom line metric cuts through the noise: "If your customer lifetime value is going up and your promo spend is going down, your brand investment is paying for itself." Translation for executives: branding works when it measurably reduces customer acquisition costs and increases retention rates. (GreenState)
From the hearing room to the comment section — we’re watching it all.
🍷 Cannabis beverages crashing wine country's most exclusive events signals the end of THC products hiding in dispensary corners. When Fable's botanical cocktails appear at Food & Wine Classic in Aspen, we're watching cultural legitimacy happen in real time. (Alcohol Professor)
🩺 Ben Carson emerges from Trump 1.0 exile to warn that rescheduling will unleash "Soros-funded activists" and turn cities into crime-ridden wastelands. The former HUD Secretary's Fox News op-ed reads like prohibition talking points from 1936, but his proximity to Trump's orbit makes this worth monitoring as potential signal from the administration's thinking. (Fox News)
🤮 Massachusetts dispensaries are now selling pumpkin spice cannabis edibles because apparently no cultural trend is safe from the relentless march of basic seasonal marketing. Peak autumn cringe has officially been achieved when your THC gummies match your latte order. (The Telegram & Gazette)